dolastatin-10 and quinoline

dolastatin-10 has been researched along with quinoline* in 1 studies

Other Studies

1 other study(ies) available for dolastatin-10 and quinoline

ArticleYear
Antineoplastic Agents. 605. Isoquinstatins.
    Journal of natural products, 2018, 03-23, Volume: 81, Issue:3

    In order to further explore quinoline-type structural modification of the powerful anticancer drug dolastatin 10, an Indian Ocean sea hare constituent and parent molecule of the very successful antibody drug conjugate (ADC) Adcetris, our recent quinstatin study has been extended by replacing the quinoline ring with an isoquinoline. The resulting isoquinstatins (4-6) were modified to N-terminal desmethylisoquinstatins (7-9) and, in turn, bonded to appropriate linker units to give linker-desmethylisoquinstatin conjugates 11-13 in preparation for eventual monoclonal antibody attachment. Comparison of the new isoquinstatins with their quinstatin counterparts against six human cancer cell lines indicated the isoquinstatins to have GI

    Topics: Antibodies, Monoclonal; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Depsipeptides; Humans; Indian Ocean; Quinolines

2018